Towards optimised information about clinical trials; identification and validation of key issues in collaboration with cancer patient advocates

European Journal of Cancer Care

Volumn 20, Issue 4, 2011, Pages 445-454

  Dellson, P ^a,b   Nilbert, M ^a,c   Bendahl, P O ^a   Malmstrom P ^b   Carlsson, C ^a,b  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c HVIDOVRE HOSPITAL   (Denmark)

Author keywords

Cancer; Clinical trials; Focus group interview; Informed consent; Patient advocates; Patient involvement

Indexed keywords

AGED; ARTICLE; BREAST TUMOR; CLINICAL TRIAL (TOPIC); FEMALE; HUMAN; INFORMATION PROCESSING; INFORMED CONSENT; INTERPERSONAL COMMUNICATION; MIDDLE AGED; PATIENT ADVOCACY; PATIENT EDUCATION; PSYCHOLOGICAL ASPECT; QUALITATIVE RESEARCH; QUESTIONNAIRE; STANDARD;

AGED; BREAST NEOPLASMS; CLINICAL TRIALS AS TOPIC; COMMUNICATION; FEMALE; FOCUS GROUPS; HUMANS; INFORMED CONSENT; MIDDLE AGED; PATIENT ADVOCACY; PATIENT EDUCATION AS TOPIC; QUALITATIVE RESEARCH; QUESTIONNAIRES;

EID: 79958270254     PISSN: 09615423     EISSN: 13652354     Source Type: Journal    
DOI: 10.1111/j.1365-2354.2010.01207.x     Document Type: Article

References (24)

1. Burnet K., Benson J., Earl H., Thornton H., Cox K. & Purushotham A.D. (2004) A survey of breast cancer patients' views on entry into several clinical studies. European Journal of Cancer Care 13, 32-35.
2. Carden C.P., Jefford M. & Rosenthal M.A. (2007) Information about cancer clinical trials: an analysis of Internet resources. European Journal of Cancer 43, 1574-1580.
3. Carlsson C., Baigi A., Killander D. & Larsson U.S. (2005) Motives for becoming and remaining member of patient associations: a study of 1, 810 Swedish individuals with cancer associations. Supportive Care in Cancer 13, 1035-1043.
4. Cox K. (2002) Informed consent and decision-making: patients' experiences of the process of recruitment to phases I and II anti-cancer drug trials. Patient Education and Counseling 46, 31-38.
5. Cox A.C., Fallowfield L.J. & Jenkins V.A. (2006a) Communication and informed consent in phase 1 trials: a review of the literature. Supportive Care in Cancer 14, 303-309.
6. Cox A., Jenkins V., Catt S., Langridge C. & Fallowfield L. (2006b) Information needs and experiences: an audit of UK cancer patients. European Journal of Oncology Nursing 10, 263-272.
7. Ellis P.M. (2000) Attitudes towards and participation in randomised clinical trials in oncology: a review of the literature. Annals of Oncology 11, 939-945.
8. Ellis P.M., Butow P.N., Tattersall M.H., Dunn S.M. & Houssami N. (2001) Randomized clinical trials in oncology: understanding and attitudes predict willingness to participate. Journal of Clinical Oncology 19, 3554-3561.
9. Fleissig A., Jenkins V. & Fallowfield L. (2001) Results of an intervention study to improve communication about randomised clinical trials of cancer therapy. European Journal of Cancer 37, 322-331.
10. Flory J. & Emanuel E. (2004) Interventions to improve research participants' understanding in informed consent for research: a systematic review. JAMA 292, 1593-1601.
11. Griffin J.M., Struve J.K., Collins D., Liu A., Nelson D.B. & Bloomfield H.E. (2006) Long term clinical trials: how much information do participants retain from the informed consent process? Contemporary Clinical Trials 27, 441-448.
12. Hietanen P.S., Aro A.R., Holli K.A., Schreck M., Peura A. & Joensuu H.T. (2007) A short communication course for physicians improves the quality of patient information in a clinical trial. Acta Oncologica 46, 42-48.
13. Hubbard G., Kidd L., Donaghy E., Mcdonald C. & Kearney N. (2007) A review of literature about involving people affected by cancer in research, policy and planning and practice. Patient Education and Counseling 65, 21-33.
14. Jayson G. & Harris J. (2006) How participants in cancer trials are chosen: ethics and conflicting interests. Nature Reviews. Cancer 6, 330-336.
15. Jenkins V.A., Fallowfield L.J., Souhami A. & Sawtell M. (1999) How do doctors explain randomised clinical trials to their patients? European Journal of Cancer 35, 1187-1193.
16. Jenkins V., Leach L., Fallowfield L., Nicholls K. & Newsham A. (2002) Describing randomisation: patients' and the public's preferences compared with clinicians' practice. The British Journal of Cancer 87, 854-858.
17. Joffe S., Cook E.F., Cleary P.D., Clark J.W. & Weeks J.C. (2001) Quality of informed consent in cancer clinical trials: a cross-sectional survey. Lancet 358, 1772-1777.
18. Morgan D. (1997) Focus Groups As Qualitative Research, 2nd edn. Sage, London, UK.
19. Rodin G., Mackay J.A., Zimmermann C., Mayer C., Howell D., Katz M., Sussman J. & Brouwers M. (2009) Clinician-patient communication: a systematic review. Supportive Care in Cancer 17, 627-644.
20. Silverman D. (2001) Interpreting Qualitative Data. Methods for Analysing Talks, Text and Interaction, 2nd edn. Sage Publications, London, UK.
21. Stryker J.E., Wray R.J., Emmons K.M., Winer E. & Demetri G. (2006) Understanding the decisions of cancer clinical trial participants to enter research studies: factors associated with informed consent, patient satisfaction, and decisional regret. Patient Education and Counseling 63, 104-109.
22. World Medical Association (1964/2008) Declaration of Helsinki. Available at.
23. Wray R.J., Stryker J.E., Winer E., Demetri G. & Emmons K.M. (2007) Do cancer patients fully understand clinical trial participation? A pilot study to assess informed consent and patient expectations. Journal of Cancer Education 22, 21-24.
24. Wright J.R., Crooks D., Ellis P.M., Mings D. & Whelan T.J. (2002) Factors that influence the recruitment of patients to Phase III studies in oncology: the perspective of the clinical research associate. Cancer 95, 1584-1591.